CVR: 16313440
Previous names: A/S PSE 38 NR. 1587, FERRING NORDIC PHARMACEUTICALS A/S
FERRING PHARMACEUTICALS A/S is a Danish company of the type Aktieselskab based in Kastrup, founded in 1992. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named FERRING NORDIC PHARMACEUTICALS A/S and A/S PSE 38 NR. 1587. The management consists of Jan Peutzfeldt, Kim Fonager Jensen and Tamara Vukmirovic. The company is owned by Ferring B.V.. The company has 556 employees. In 2025, the company reported revenue of DKK 1,730,413,000 and a net result of DKK 49,005,000 compared with DKK 76,890,000 the year before. Equity amounted to DKK 315,220,000.
Ferring Pharmaceuticals A/S demonstrates a solid financial trajectory, with revenue increasing from 1,005 million DKK in 2021 to 1,730 million DKK in 2025. Profitability has also shown resilience, peaking at 76.9 million DKK in 2024, although it dipped to 49 million DKK in 2025. The company's equity has significantly improved, rising from 69.6 million DKK in 2021 to 315.2 million DKK in 2025, indicating a strong capital base. However, the fluctuating profit margins may raise concerns about operational efficiency. Overall, Ferring holds a notable position in the research and experimental development sector, characterized by steady growth and a robust equity position.
AI-generated summary
Your company? Claim the profile and show your logo, website and social channels — for free.
Claim this profileSelskabets formål er forskning og udvikling af farmaceutiske produkter for selskaber i Ferring koncernen.
| Year | Revenue | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 2025 | 1.7 mia. | 49 mio. | 671.1 mio. | 315.2 mio. | 577 | |
| 2024 | 1.7 mia. | 76.9 mio. | 554.5 mio. | 266.2 mio. | 487 | |
| 2023 | 1.5 mia. | 67.1 mio. | 586.4 mio. | 189.3 mio. | 497 | |
| 2022 | 1.3 mia. | 52.4 mio. | 485.7 mio. | 122 mio. | 559 | |
| 2021 | 1 mia. | 40.2 mio. | 472.9 mio. | 69.6 mio. | 487 | |
| 2020 | 1.1 mia. | 40.9 mio. | 381.8 mio. | 79.4 mio. | 497 | |
| 2019 | 1.4 mia. | 38.3 mio. | 378.2 mio. | 106.5 mio. | 533 | |
| 2018 | 1.4 mia. | 56.1 mio. | 397.9 mio. | 118.2 mio. | 525 | |
| 2017 | 1.3 mia. | 54.7 mio. | 376.9 mio. | 112.1 mio. | 548 | |
| 2016 | 1.2 mia. | 50.3 mio. | 353 mio. | 97.4 mio. | 491 | |
| 2015 | 1.3 mia. | 51.6 mio. | 285.7 mio. | 86.1 mio. | 467 | |
| 2014 | 1.2 mia. | 47.9 mio. | 317.9 mio. | 109.5 mio. | 463 | |
| 2013 | 1.1 mia. | 43.8 mio. | 297.7 mio. | 117.6 mio. | 407 |
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorCompared to 1.053 companies in Forskning og eksperimentel udvikling inden for naturvidenskab og teknik
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
FERRING PHARMACEUTICALS A/S has published its annual report for 2025. Revenue came to DKK 1,730,413,000, and the net result was DKK 49,005,000.
As of March 23, 2026, Pierre Yves Berclaz has left the board of directors of FERRING PHARMACEUTICALS A/S.
As of February 1, 2026, Ingbritt Tolstrup Birk is registered as director of FERRING PHARMACEUTICALS A/S.
As of February 1, 2026, Lene Melchiorsen has stepped down as director of FERRING PHARMACEUTICALS A/S.
As of October 24, 2025, Tamara Vukmirovic is registered as director of FERRING PHARMACEUTICALS A/S.
As of September 15, 2025, Jesper Thomsen has joined the board of directors of FERRING PHARMACEUTICALS A/S.
As of September 15, 2025, Jesper Thomsen has left the board of directors of FERRING PHARMACEUTICALS A/S.
As of September 15, 2025, Jesper Thomsen is registered as director of FERRING PHARMACEUTICALS A/S.
As of July 21, 2025, Anette Hedegaard Østergaard has stepped down as director of FERRING PHARMACEUTICALS A/S.
As of July 21, 2025, Klaus Grønbæk Jakobsen has stepped down as director of FERRING PHARMACEUTICALS A/S.
FERRING PHARMACEUTICALS A/S has published its annual report for 2024. Revenue came to DKK 1,690,294,000, and the net result was DKK 76,890,000.
FERRING PHARMACEUTICALS A/S has published its annual report for 2023. Revenue came to DKK 1,457,509,000, and the net result was DKK 67,110,000.
As of March 1, 2024, Pierre Yves Berclaz has joined the board of directors of FERRING PHARMACEUTICALS A/S.
As of March 1, 2024, Jean-Frederic Paulsen has joined the board of directors of FERRING PHARMACEUTICALS A/S.
As of March 1, 2024, Armin Metzger has left the board of directors of FERRING PHARMACEUTICALS A/S.
As of March 1, 2024, Anette Hedegaard Østergaard is registered as director of FERRING PHARMACEUTICALS A/S.
As of February 1, 2024, Marianne Kock has joined the board of directors of FERRING PHARMACEUTICALS A/S.
As of February 1, 2024, Per Gunnar Falk has left the board of directors of FERRING PHARMACEUTICALS A/S.
As of February 1, 2024, Jan Peutzfeldt is registered as adm. dir. of FERRING PHARMACEUTICALS A/S.
As of February 1, 2024, Marianne Kock has stepped down as adm. dir. of FERRING PHARMACEUTICALS A/S.
As of January 31, 2024, Marianne Kock has left the board of directors of FERRING PHARMACEUTICALS A/S.
As of December 22, 2023, Klaus Grønbæk Jakobsen is registered as director of FERRING PHARMACEUTICALS A/S.
As of December 22, 2023, Lene Melchiorsen is registered as director of FERRING PHARMACEUTICALS A/S.
As of August 11, 2023, Armin Metzger has joined the board of directors of FERRING PHARMACEUTICALS A/S.
As of August 1, 2023, Bolette Wildt has stepped down as director of FERRING PHARMACEUTICALS A/S.
FERRING PHARMACEUTICALS A/S has published its annual report for 2022. Revenue came to DKK 1,261,432,000, and the net result was DKK 52,377,000.
FERRING PHARMACEUTICALS A/S has published its annual report for 2021. Revenue came to DKK 1,005,468,000, and the net result was DKK 40,174,000.
As of December 10, 2021, Marianne Kock has joined the board of directors of FERRING PHARMACEUTICALS A/S.
As of December 10, 2021, Per Gunnar Falk has joined the board of directors of FERRING PHARMACEUTICALS A/S.
As of December 10, 2021, Ole Kjerulf-Jensen has left the board of directors of FERRING PHARMACEUTICALS A/S.
As of December 10, 2021, Bolette Wildt is registered as director of FERRING PHARMACEUTICALS A/S.
As of December 10, 2021, Kim Fonager Jensen is registered as director of FERRING PHARMACEUTICALS A/S.
As of December 9, 2021, Per Gunnar Falk has left the board of directors of FERRING PHARMACEUTICALS A/S.
FERRING PHARMACEUTICALS A/S has published its annual report for 2020. Revenue came to DKK 1,051,468,000, and the net result was DKK 40,928,000.
FERRING PHARMACEUTICALS A/S has published its annual report for 2019. Revenue came to DKK 1,380,192,000, and the net result was DKK 38,281,000.
FERRING PHARMACEUTICALS A/S has published its annual report for 2018. Revenue came to DKK 1,401,012,000, and the net result was DKK 56,130,000.
FERRING PHARMACEUTICALS A/S has published its annual report for 2017. Revenue came to DKK 1,332,355,000, and the net result was DKK 54,688,000.
FERRING PHARMACEUTICALS A/S has published its annual report for 2016. Revenue came to DKK 1,225,924,000, and the net result was DKK 50,325,000.
As of March 14, 2017, Per Gunnar Falk has joined the board of directors of FERRING PHARMACEUTICALS A/S.
As of March 14, 2017, Pascal Rene Olivier Danglas has left the board of directors of FERRING PHARMACEUTICALS A/S.
FERRING PHARMACEUTICALS A/S has published its annual report for 2015. Revenue came to DKK 1,269,951,000, and the net result was DKK 51,621,000.
FERRING PHARMACEUTICALS A/S has published its annual report for 2014. Revenue came to DKK 1,206,882,000, and the net result was DKK 47,850,000.
As of February 1, 2015, Pascal Rene Olivier Danglas has stepped down as director of FERRING PHARMACEUTICALS A/S.
FERRING PHARMACEUTICALS A/S has published its annual report for 2013. Revenue came to DKK 1,102,920,000, and the net result was DKK 43,830,000.
As of January 1, 2014, DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of FERRING PHARMACEUTICALS A/S.
As of December 31, 2013, PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB has stepped down as auditor of FERRING PHARMACEUTICALS A/S.
FERRING PHARMACEUTICALS A/S has published its annual report for 2012.
As of July 1, 2011, PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of FERRING PHARMACEUTICALS A/S.
As of July 1, 2011, A/S PSE NR. 4820 has stepped down as auditor of FERRING PHARMACEUTICALS A/S.
As of June 6, 2006, Marianne Kock is registered as adm. dir. of FERRING PHARMACEUTICALS A/S.
As of June 5, 2006, Marianne Kock has stepped down as director of FERRING PHARMACEUTICALS A/S.
As of May 18, 2006, Marianne Kock is registered as director of FERRING PHARMACEUTICALS A/S.
As of August 24, 2005, Ole Kjerulf-Jensen has joined the board of directors of FERRING PHARMACEUTICALS A/S.
As of August 24, 2005, Dag Frederik Arfst Paulsen has joined the board of directors of FERRING PHARMACEUTICALS A/S.
As of August 24, 2005, Ole Kjerulf-Jensen is registered as director of FERRING PHARMACEUTICALS A/S.
As of August 24, 2005, Pascal Rene Olivier Danglas is registered as director of FERRING PHARMACEUTICALS A/S.
As of August 24, 2005, Ole Kjerulf-Jensen has stepped down as director of FERRING PHARMACEUTICALS A/S.
As of August 15, 2005, Jeffrey David Hobbs has left the board of directors of FERRING PHARMACEUTICALS A/S.
As of June 14, 2004, Pascal Rene Olivier Danglas has joined the board of directors of FERRING PHARMACEUTICALS A/S.
As of November 30, 2001, Christiaan Paul Thomas has left the board of directors of FERRING PHARMACEUTICALS A/S.
As of November 30, 2001, Christiaan Paul Thomas has stepped down as director of FERRING PHARMACEUTICALS A/S.
As of December 20, 2000, Jean Louis Junien has left the board of directors of FERRING PHARMACEUTICALS A/S.
On February 9, 1999, the company changed its name from FERRING NORDIC PHARMACEUTICALS A/S to FERRING PHARMACEUTICALS A/S.
As of October 7, 1998, Jeffrey David Hobbs has joined the board of directors of FERRING PHARMACEUTICALS A/S.
As of October 7, 1998, Jean Louis Junien has joined the board of directors of FERRING PHARMACEUTICALS A/S.
As of October 7, 1998, Mats Lundwall has left the board of directors of FERRING PHARMACEUTICALS A/S.
As of October 7, 1998, Christiaan Paul Thomas is registered as director of FERRING PHARMACEUTICALS A/S.
As of October 7, 1998, Mats Lundwall has stepped down as director of FERRING PHARMACEUTICALS A/S.
As of March 13, 1998, Åke Stefan Warin has stepped down as director of FERRING PHARMACEUTICALS A/S.
As of February 12, 1998, Christiaan Paul Thomas has joined the board of directors of FERRING PHARMACEUTICALS A/S.
As of February 12, 1998, Eva Wolf Paulsen has left the board of directors of FERRING PHARMACEUTICALS A/S.
As of January 1, 1997, is registered as an owner of FERRING PHARMACEUTICALS A/S with an ownership share of 100%.
As of June 28, 1995, John Voigt has stepped down as auditor of FERRING PHARMACEUTICALS A/S.
As of May 4, 1995, A/S PSE NR. 4820 has been appointed auditor of FERRING PHARMACEUTICALS A/S.
As of December 7, 1994, Eva Wolf Paulsen has stepped down as director of FERRING PHARMACEUTICALS A/S.
On September 22, 1993, the company changed its name from A/S PSE 38 NR. 1587 to FERRING NORDIC PHARMACEUTICALS A/S.
As of September 21, 1993, Erik Tronborg Andersen has stepped down as auditor of FERRING PHARMACEUTICALS A/S.
As of September 21, 1993, Hans Christian Galst has left the board of directors of FERRING PHARMACEUTICALS A/S.
As of September 21, 1993, Ulf Svejgaard Poulsen has left the board of directors of FERRING PHARMACEUTICALS A/S.
As of September 21, 1993, Per Emil Hasselbalch Stakemann has left the board of directors of FERRING PHARMACEUTICALS A/S.
As of September 21, 1993, Per Emil Hasselbalch Stakemann has stepped down as director of FERRING PHARMACEUTICALS A/S.
As of August 1, 1992, Erik Tronborg Andersen has been appointed auditor of FERRING PHARMACEUTICALS A/S.
As of August 1, 1992, John Voigt has been appointed auditor of FERRING PHARMACEUTICALS A/S.
As of August 1, 1992, Hans Christian Galst has joined the board of directors of FERRING PHARMACEUTICALS A/S.
As of August 1, 1992, Ulf Svejgaard Poulsen has joined the board of directors of FERRING PHARMACEUTICALS A/S.
As of August 1, 1992, Per Emil Hasselbalch Stakemann has joined the board of directors of FERRING PHARMACEUTICALS A/S.
As of August 1, 1992, Eva Wolf Paulsen has joined the board of directors of FERRING PHARMACEUTICALS A/S.
As of August 1, 1992, Mats Lundwall has joined the board of directors of FERRING PHARMACEUTICALS A/S.
As of August 1, 1992, Per Emil Hasselbalch Stakemann is registered as director of FERRING PHARMACEUTICALS A/S.
As of August 1, 1992, Eva Wolf Paulsen is registered as director of FERRING PHARMACEUTICALS A/S.
As of August 1, 1992, Åke Stefan Warin is registered as director of FERRING PHARMACEUTICALS A/S.
FERRING PHARMACEUTICALS A/S was founded on August 1, 1992.
As of March 13, 1980, Mats Lundwall is registered as director of FERRING PHARMACEUTICALS A/S.
Companies in the same industry and area
CVR 34715726
CVR 41277688
CVR 37723312
CVR 44821494
CVR 38789902
companydata.dk